Verrica Pharmaceuticals Inc (VRCA)
0.7043
-0.04
(-5.63%)
USD |
NASDAQ |
Nov 07, 16:00
0.72
+0.02
(+2.23%)
Pre-Market: 08:44
Verrica Pharmaceuticals Revenue (Annual): 5.124M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 5.124M |
December 31, 2022 | 9.032M |
Date | Value |
---|---|
December 31, 2021 | 12.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
5.124M
Minimum
2023
12.00M
Maximum
2021
8.719M
Average
9.032M
Median
2022
Revenue (Annual) Benchmarks
Biomarin Pharmaceutical Inc | 2.419B |
Elite Pharmaceuticals Inc | 56.63M |
Eagle Pharmaceuticals Inc | -- |
TELA Bio Inc | 58.45M |
Terns Pharmaceuticals Inc | -- |